Medisafe gets $14.5M in Series B, opens office in London

The funds will be used to support the company's rapid growth and brings its personalized medication management platform to other places.
Medisafe app

Medisafe’s new feature alerts users of potentially harmful drug interactions

The interactions feature also includes disclosures when medications have other lifestyle implications, such as interactions with specific foods or alcohol.
Medisafe

Medisafe’s app to be tested with hypertension patients

Boston's Brigham and Women's Hospital and Evidation Health will test Medisafe's medication adherence app in a randomized control trial of 390 patients.
Medisafe iConnect

Medisafe, TimerCap launch mobile-connected pill organizers

The new Medisafe iConnect devices, including iCap and iSort, are Bluetooth connected and can work in tandem with Medisafe's software.
Medisafe app

Medisafe, Nestlé Health Science to help patients prepare for surgery

Personalized adherence platform will be used to help patients take Nestlé Health Science's IMPACT ADVANCED RECOVERY Specialized Nutrition Drink.
Medisafe

Medisafe Providers enables doctors to track their patients’ medication adherence

The new, adherence feature is visible alongside patient biometric measurements such as blood pressure, glucose, weight, and so on.
Medisafe

Medisafe integrates with GoodRx to help users lower medication costs

Thanks to the new feature, users will benefit from localized coupons integrated into Medisafe's app for more than 80 percent off list prices.
Omri Shor

Interview with Omri Shor, CEO of Medisafe

Medisafe is the award winning, data driven Medication Management Platform created to improve patient engagement and raise medication adherence.
Medisafe

Medisafe adds biometric integration to its medication adherence platform

Patients will be able to visualize in real-time how taking medication or missing a dose impacts important biometrics, such as glucose levels and blood pressure.
MediSafe

MediSafe raises $6M, relocates HQ to the United States

The company will use the new funds to accelerate growth in the U.S. market, where nearly half of Americans are prescribed at least one medication per day.